1. Home
  2. STOK vs CYD Comparison

STOK vs CYD Comparison

Compare STOK & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$33.14

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$34.80

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
CYD
Founded
2014
1951
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
STOK
CYD
Price
$33.14
$34.80
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$31.00
N/A
AVG Volume (30 Days)
880.4K
160.4K
Earning Date
11-04-2025
08-08-2025
Dividend Yield
N/A
1.52%
EPS Growth
N/A
40.10
EPS
0.68
1.66
Revenue
$205,632,000.00
$3,159,401,156.00
Revenue This Year
$430.24
$41.12
Revenue Next Year
N/A
$6.93
P/E Ratio
$45.09
$20.90
Revenue Growth
1128.17
17.99
52 Week Low
$5.35
$8.61
52 Week High
$38.69
$42.60

Technical Indicators

Market Signals
Indicator
STOK
CYD
Relative Strength Index (RSI) 65.66 44.51
Support Level $28.74 $34.75
Resistance Level $31.44 $36.30
Average True Range (ATR) 1.83 1.51
MACD 0.38 -0.03
Stochastic Oscillator 95.76 46.61

Price Performance

Historical Comparison
STOK
CYD

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: